Name: ABSA’s 1st Biosecurity Symposium
Start: 2021-04-20T00:00:00-05:00
End: 2021-04-23T23:59:59-05:00
Location: Renaissance Depot Hotel

Large Clinical Trial in Africa Tests Treatments for Mild and Moderate COVID-19 Cases

Attributes and Predictors of Long-COVID
MIS-C Detection: BARDA Invests in Rapid Diagnostic for Pediatric Complication of SARS-CoV-2
Dublin-Boston Scoring System Helps Predict Which COVID-19 Patients Will Develop Severe Infection

Autoimmune-Like Antibody Response Linked with Severe COVID-19

by Matthew Woodruff October 10, 2020, 8:30 am
Here’s What We Know So Far About Pediatric Multisystem Inflammatory Syndrome (MIS-C)

by Ritu Banerjee September 10, 2020, 2:08 pm
COVID-19 Patients Suffer Long-Term Heart and Lung Damage But It Can Improve With Time

by Global Biodefense Staff September 6, 2020, 4:17 pm
People with Zika Antibodies More Vulnerable to Severe Dengue Disease

by Global Biodefense Staff August 27, 2020, 8:09 am

Medicine-Health

Large Clinical Trial in Africa Tests Treatments for Mild and Moderate COVID-19 Cases

Attributes and Predictors of Long-COVID

MIS-C Detection: BARDA Invests in Rapid Diagnostic for Pediatric Complication of SARS-CoV-2

Dublin-Boston Scoring System Helps Predict Which COVID-19 Patients Will Develop Severe Infection

Autoimmune-Like Antibody Response Linked with Severe COVID-19

Here’s What We Know So Far About Pediatric Multisystem Inflammatory Syndrome (MIS-C)

COVID-19 Patients Suffer Long-Term Heart and Lung Damage But It Can Improve With Time

People with Zika Antibodies More Vulnerable to Severe Dengue Disease

Biodefense Headlines – 21 January 2021

First Cases of B.1.1.7 Variant COVID-19 Detected in Washington State

The Response Measures Database: Central Archive of COVID-19 Interventions

EU Initiative on Health Security Work Programme 2021

Rapid Identification of Ricin in Serum Samples Using LC–MS/MS

Dr. Fauci Makes First Appearance at Biden White House Press Briefing – Transcript

ASM Expresses Support for the Global Health Security Act of 2021

How and When Will Lower-Income Countries Gain Access to COVID-19 Vaccines?

OHDSI Awarded $10M FDA Contract to Monitor Safety and Effectiveness of Vaccines, Biologics

Neutralizing Norovirus: NIAID Monoclonal Antibodies Licensing Opportunity

NIAID Looks Ahead to Pan-Coronavirus Vaccine Candidates

DRIVE ReDIRECT: Program Seeks to Develop Countermeasures Against Chemical Threats

Emerging Infections Network – Managing Travelers Who Acquire Disease Abroad

Upcoming Events

Application Deadline: Expanding Existing Research Grants, CRADAs for Novel Coronavirus Response

Envisioning a Transformed Clinical Trials Enterprise for 2030 – Session 2

Systematizing the One Health Approach in Preparedness and Response Efforts for Infectious Disease Outbreaks

Envisioning a Transformed Clinical Trials Enterprise for 2030 – Session 3

ABSA’s 1st Biosecurity Symposium

Latest stories

Latest Articles